KVUE
Kenvue Inc.
NYSE · Consumer Defensive · Household & Personal Products · US
$19.56
+1.19%Oct 28, 2026, 01:29 UTC
Kimberly-Clark extended the expiration date of its exchange offers for Kenvue notes for up to $7 billion aggregate principal amount of new Kimberly-Clark notes.
Source:Oct 21, 2026, 21:00 UTC
Kenvue announced that it will release its third-quarter 2026 financial results before the market opens on October 30, 2026, and will not host a quarterly conference call because of its pending transaction with KIMBERLY CLARK CORP.
Source:Oct 20, 2026, 14:07 UTC
China approved KIMBERLY CLARK CORP's $40 billion purchase of Kenvue Inc..
Source:Oct 20, 2026, 07:48 UTC
China’s State Administration for Market Regulation published a list of unconditional approvals for 14 business-concentration cases covering October 5–11, 2026, including acquisitions and newly established joint ventures.
Source:Oct 19, 2026, 12:26 UTC
KIMBERLY CLARK CORP is selling investment-grade bonds in as many as five parts to help fund its pending acquisition of Kenvue Inc..
Source:Oct 14, 2026, 23:59 UTC
Sunscreens containing bemotrizinol began arriving on U.S. store shelves, including products from Kenvue Inc. and other manufacturers.
Oct 7, 2026, 06:45 UTC
SPJIMR reported that all 365 participants in its Class of 2028 secured summer internships, with a median monthly stipend of ₹2 lakhs, an average of ₹1.86 lakhs and a highest stipend of ₹3 lakhs.
Source:Sep 21, 2026, 13:45 UTC
Aveeno Baby launched contextual advertising on ChatGPT in India, executed by Zenith Media, becoming Kenvue's first brand to run such an initiative.
Source:Sep 15, 2026, 15:30 UTC
Kenvue, the maker of Tylenol, along with pharmacy chains Walgreens, CVS, Walmart and Target, asked the Second U.S. Circuit Court of Appeals to reconsider its July 13, 2026 ruling that revived more than 500 autism-related acetaminophen lawsuits.
Source:Sep 14, 2026, 06:15 UTC
Sorbent Paper Company signed an agreement with Kenvue's Singaporean subsidiary to acquire the Stayfree and Carefree feminine care business in Australia and New Zealand, with the New Zealand business to be managed by Sorbent affiliate Cottonsoft after closing.
Source:Sep 10, 2026, 10:45 UTC
Kenvue Inc.'s Board of Directors declared a quarterly cash dividend of $0.21 per share on its common stock, payable on October 2, 2026 to shareholders of record as of September 21, 2026.
Source:Aug 24, 2026, 17:00 UTC
BBB National Programs' National Advertising Division ruled on a challenge by Kenvue Inc., finding that Hims & Hers Health, Inc. had support for its comparative efficacy claim but recommending modification or discontinuance of other advertising claims.
Source:Aug 23, 2026, 03:50 UTC
India's food safety regulator FSSAI issued over 150 notices to major food and beverage companies including Nestle India, PepsiCo, Coca-Cola India, and Red Bull India for misleading advertisements, false claims, and labelling non-compliances.
Aug 20, 2026, 07:18 UTC
AssuredPartners Investment Advisors LLC acquired a new position of 32,710 shares in Kenvue Inc. (NYSE: KVUE), valued at approximately $625,000, as disclosed in a recent SEC filing.
Source:Aug 20, 2026, 03:15 UTC
Essity agreed to acquire Kenvue's feminine care business in Brazil, including the Carefree, Sempre Livre and o.b. brands, for USD 284 million on a cash and debt-free basis, expected to close in Q2 2027.
Aug 18, 2026, 07:50 UTC
B & T Capital Management DBA Alpha Capital Management acquired a new stake in Kenvue Inc. during the second quarter of 2026, purchasing 265,605 shares valued at approximately $5,076,000.
Source:Aug 12, 2026, 05:09 UTC
Meituan's core local commerce CEO Wang Puzhong announced at the Xipu Conference that Meituan is opening its AI business expert capabilities and CatPaw AI Agent platform to pharmaceutical merchants, with initial AI business experts already applied at Shuyu Pingmin and Kenvue.
Source:Aug 6, 2026, 10:45 UTC
Kenvue Inc. announced financial results for its fiscal second quarter ended June 28, 2026, reporting its third consecutive quarter of net and organic sales growth across all segments and regions.
Jul 29, 2026, 10:45 UTC
Kenvue Inc. announced a quarterly cash dividend of $0.21 per share, a 1.2% increase from the prior dividend, payable on August 26, 2026 to shareholders of record on August 12, 2026.
Source:Jul 24, 2026, 16:00 UTC
The U.S. Food and Drug Administration approved an over-the-counter fixed-dose combination pill of Kenvue's Tylenol and naproxen for pain relief.
Source:Jul 10, 2026, 20:30 UTC
The Illinois Appellate Court affirmed a $45 million jury verdict against Johnson & Johnson and Kenvue in a mesothelioma lawsuit brought by the family of Theresa Garcia.
Source: